Unlock instant, AI-driven research and patent intelligence for your innovation.

Nano-encapsulated, controlled drug delivery, manufacturing process and system

Inactive Publication Date: 2014-08-28
ZENG ALBERT SOLUR
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent is about a way to make small medication capsules that release their drugs over time. This can help with giving drugs that can be harder to administer and may have lower toxicity. It can also make the medication easier to use and require fewer administrations. This technology can be cost-effective and efficient.

Problems solved by technology

Moreover, this Summary is not intended for use as an aid in determining the scope of the claimed subject matter.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nano-encapsulated, controlled drug delivery, manufacturing process and system
  • Nano-encapsulated, controlled drug delivery, manufacturing process and system
  • Nano-encapsulated, controlled drug delivery, manufacturing process and system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029]What follows is a detailed description of the preferred embodiments of the invention in which the invention may be practiced. Reference will be made to the attached drawings, and the information included in the drawings is part of this detailed description. The specific preferred embodiments of the invention, which will be described herein, are presented for exemplification purposes, and not for limitation purposes. It should be understood that structural and / or logical modifications could be made by someone of ordinary skills in the art without departing from the scope of the invention. Therefore, the scope of the invention is defined by the accompanying claims and their equivalents.

[0030]For the purpose of this disclosure, the protective material that constitutes the coating layer(s) for the core nanodrug may be a polymer or any other suitable biodegradable material.

[0031]For the purpose of this disclosure, the configuration(s) of the material that constitutes the coating la...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A mixed dose of a nanosized drug wherein at least one portion of the mixed dose comprises a core nanosized drug encapsulated in at least one layer of a protective material having the same core drug or different core drug. A mixed dose of a nanosized drug wherein at least one portion of the mixed dose comprises a core nanosized drug encapsulated in at least one shell of a protective material with same drug concentration or different drug concentrations. A mixed dose of a nanosized drug wherein at least one portion of the mixed dose comprises a core nanosized drug encapsulated such that to have different release schedule than the other portions of the drug. Methods and systems for the manufacturing and the administration of nanosized encapsulated drugs are also provided.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a divisional application of U.S. Non-provisional application Ser. No. 13 / 775,016, filed Feb. 22, 2013, the benefit of which is claimed and the content of which is incorporated by reference.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The invention relates generally to nanobiopharmaceutics and more particularly to nano-encapsulated drugs, their controlled and / or scheduled delivery method, manufacturing process and system for processing nano size, delivery controlled encapsulated drugs.[0004]2. Description of the Related Art[0005]Traditional medicine administered orally may have a slower and less complete absorption than medicine administered using parenteral (non-oral) routes. Dissolution of solid formulations (e.g., tablets) must occur first. The drug must survive exposure to stomach acid and this route of administration is subject to the first pass effect (metabolism of a significant amount of drug ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/51
CPCA61K9/5192B82Y40/00B82Y5/00A61K9/5084
Inventor ZENG, ALBERT SOLUR
Owner ZENG ALBERT SOLUR